Drug addiction: A general review of new concepts and future challenges

Eastern Mediterranean Health Journal

Volumn 6, Issue 4, 2000, Pages 723-733

  Qureshi, N A ^a   Al Ghamdy, Y S ^b   Al Habeeb, T A ^c  

^a Buraidah Mental Health Hospital   (Saudi Arabia)

^b General Directorate of Health Affairs   (Saudi Arabia)

^c KING KHALID UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ADDICTION; ANIMAL; CHRONIC DISEASE; DISEASE MODEL; FORECASTING; GENE THERAPY; HUMAN; NEUROBIOLOGY; PATHOPHYSIOLOGY; PSYCHOLOGICAL ASPECT; PUBLIC HEALTH; RECURRENT DISEASE; RESEARCH; REVIEW; WITHDRAWAL SYNDROME;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FORECASTING; GENE THERAPY; HUMANS; NEUROBIOLOGY; PUBLIC HEALTH; RECURRENCE; RESEARCH; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS;

EID: 0034236465     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. Institute of Medicine. Pathways of addiction. Washington DC, National Academy Press, 1996.
2. Diagnostic and statistical manual of mental disorders: DSM-IV, 4th ed. Washington DC, American Psychiatric Association, 1994.
3. International classification of diseases and related health problems, 10th ed. Geneva, World Health Organization, 1992.
4. Heather N. A conceptual framework for explaining drug addiction. Journal of psychopharmacology, 1998, 12:3-7.
5. Bigelow GE, Brooner RK, Silverman K. Competing motivations: drug reinforcement vs non-drug reinforcement. Journal of psychopharmacology, 1998, 12:8-14.
6. O'Brien CP et al. Conditioning factors in drug abuse: can they explain compulsion? Journal of psychopharmacology, 1998, 12:15-22.
7. Tiffany ST, Carter BL. Is craving the source of compulsive drug use? Journal of psychopharmacology, 1998, 12:23-30.
8. Koob GF et al. Substance dependence as a compulsive behavior. Journal of psychopharmacology, 1998, 12:39-48.
9. Di Chiara G. A motivational learning hypothesis of the role of mesolimbic dopamine in compulsive drug use. Journal of psychopharmacology, 1998, 12:54-67.
10. Matsuda LA et al. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 1990, 346:561-4.
11. Vogel G. Cocaine wreaks subtle damage on developing brains. Science, 1997, 278:38-9.
12. Chang L et al. Gender effects on persistent cerebral metabolite changes in the frontal lobes of abstinent cocaine abusers. American journal of psychiatry, 1999, 156:716-22.
13. Nesse RM, Berridge KC. Psychoactive drug use in evolutionary perspective. Science, 1997, 278,63-6.
14. Kosten TR. Addiction as a brain disease. American journal of psychiatry, 1998, 155:711-3.
15. Koob GF, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science, 1997, 278:52-8.
16. Leshner AI. Addiction is a brain disease, and it matters. Science, 1997, 278:45-7.
17. O'Brien CP. Progress in the science of addiction. American journal of psychiatry, 1997, 154:1195-7.
18. Kraft MK et al. Are supplementary services provided during methadone maintenance really cost-effective? American journal of psychiatry, 1997, 154:1214-9.
19. Kushner MG, Sher KJ, Erickson DJ. Prospective analysis of the relation between DSM-111 anxiety disorders and alcohol use disorders. American journal of psychiatry, 1999, 156:723-32.
20. Qureshi NA. Sociodemographic correlates, pattern, and co-morbidity of drug abuse among psychiatric patients. Arab journal of psychiatry, 1992, 3:98-106.
21. Skodol AE, Oldham JM, Gallaher PE. Axis II co-morbidity of substance use disorders among patients referred for treatment of personality disorders. American journal of psychiatry, 1999, 156:733-8.
22. MacCoun R, Reuter P. Interpreting Dutch cannabis policy: reasoning by analogy in the legalization debate. Science, 1997, 278:47-52.
23. Nestler EJ, Aghajanian GK. Molecular and cellular basis of addiction. Science, 1997, 278:58-63.
24. O'Brien CP. Experimental analysis of conditioning factors in human narcotic addiction. Pharmacological review, 1975, 27:533-43.
25. Nestler EJ, Hope BR, Windell KL. Drug addiction: a model for the molecular basis of neural plasticity. Neuron, 1993, 11:995-1006.
26. Little KY et al. Cocaine, ethanol, and genotype effects on human midbrain serotonin transporter binding sites and mRNA levels. American journal of psychiatry, 1998, 155:207-13.
27. Gelernter J et al. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology, 1994, 11:195-200.
28. Lander AR, Schork NJ. Genetic dissection of complex traits. Science, 1994, 265:2037-48.
29. Sanders AR, Gershon ES. Images in neuroscience. Clinical genetics, VIII. From genetics to pathophysiology - candidate genes. American journal of psychiatry, 1998, 155:162.
30. Schuckit MA et al. Clinical relevance of the distinction between alcohol dependence with and without a physiological component. American journal of psychiatry, 1998, 155:733-40.
31. Carroll KM, Rounsaville BJ, Bryant KJ. Should tolerance and withdrawal be required for substance dependence disorders? Drug and alcohol dependence, 1994, 36:15-22.
32. Sander T et al. Association analysis of a regulatory variation of the serotonin transporter gene with severe alcohol dependence. Alcoholism, clinical and experimental research, 1997, 21:1356-9.
33. Kendler KS, Prescott CA. Cannabis use, abuse, and dependence in a population-based sample of female twins. American journal of psychiatry, 1998, 155:1016-22.
34. Miyakawa T et al. Fyn-kinase as a determinant of ethanol sensitivity: relation to NMDA-receptor function. Science, 1997, 278:698-701.
35. Cloninger CR. A systematic method for clinical description and classification of personality variants: a proposal. Archives of general psychiatry, 1987, 44:573-88.
36. Sullivan PF et al. No association between novelty seeking and the type 4 dopamine receptor gene (DRD4) in two New Zealand samples. American journal of psychiatry, 1998, 155:98-101.
37. Cloninger CR. Neurogenetic adaptative mechanisms in alcoholism. Science, 1987, 236:410-6.
38. Wickelgren I. Getting the brain's attention. Science, 1997, 278:35-7.
39. Heinz A et al. In vivo association between alcohol intoxication, aggression, and serotonin transporter availability in non-human primates. American journal of psychiatry, 1998, 155:1023-8.
40. Wickelgren I. Teaching the brain to take drugs. Science, 1998, 280:2045-6.
41. Kentros C et al. Abolition of long-term stability of new hippocampal place cell maps by NMDA receptor blockade. Science, 1998, 280:2121-6.
42. Tanda G, Pontieri FE, Di Chiara G. Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common mu1 opioid receptor mechanism. Science, 1997, 276:2048-50.
43. Rodriguez de Fonesca F et al. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science, 1997, 276:2050-4.
44. Bucholz KK et al. Can we subtype alcoholism? A latent class analysis of data from relatives of alcoholics in a multicenter family study of alcoholism. Alcoholism, clinical and experimental research, 1996, 20:1462-71.
45. Rounsaville BJ, Bryant KJ. Tolerance and withdrawal in the DSM-111-R diagnosis of substance dependence: utility in a cocaine-using population. American journal on addictions, 1992, 1:50-60.
46. Edwards G. Withdrawal symptoms and alcohol dependence: fruitful mysteries. British journal of addiction, 1990, 85:447-67.
47. Schuckit MA. Substance-related disorders. In: Widiger TA et al., eds. DSM-IV sourcebook, vol. 1 Washington DC, American Psychiatric Association, 1994: 5-19.
48. Cottler LB et al. Agreement between DSM-III and III-R substance use disorders. Drug and alcohol dependence, 1991, 29:17-25.
49. Cottler LB et al. The DSM-IV field trial for substance use disorders: major results. Drug and alcohol dependence, 1995, 38:59-69.
50. Nathan PE. Psychoactive substance dependence. In: Widiger TA et al., eds. DSM-IV sourcebook, vol. 1 Washington DC, American Psychiatric Association, 1994: 33-43.
51. Skinner HA. Alcohol dependence: how does it come about? British journal of addiction, 1986, 81:279-84.
52. Kalant H, Nathan B. Eddy memorial award lecture: tolerance and its significance for drug and alcohol dependence. MDA research monograph, 1987, 76:9-19.
53. Tabakoff B. One man's craving is another man's dependence. British journal of addiction, 1990, 85:1253-4.
54. Langenbucher J et al. Physiological alcohol dependence as a "specifier" of risk for medical and relapse liability in DSM-IV. Journal of studies on alcoholism, 1997, 58:341-50.
55. Schmidt LG et al. Modification of alcohol withdrawal by the A9 allele of the dopamine transporter gene. American journal of psychiatry, 1998, 155:474-8.
56. Muramatsu T, Higuchi S. Dopamine transporter gene polymorphism and alcoholism. Biochemical and biophysical research communications, 1995, 211:28-32.
57. Harris GC, Aston-Jones G. Involvement of D2 dopamine receptors in the nucleus accumbens in the opiate withdrawal syndrome. Nature, 1994, 371:155-7.
58. Glue P, Nutt D. Overexcitement and disinhibition. Dynamic neurotransmitter interactions in alcohol withdrawal. British journal of psychiatry, 1990, 157:491-9.
59. Hawley RJ et al. Neurochemical correlates of sympathetic activation during severe alcohol withdrawal. Alcoholism, clinical and experimental research, 1994, 18:1312-6.